September 27, 2022

On September 22, 2022, to help achieve its priority of expanding the availability of overdose reversal products, the U.S. Food and Drug Administration issued the Exemption and Exclusion from Certain Requirements of the Drug Supply Chain Security Act for the Distribution of FDA-Approved Naloxone Products During the Opioid Public Health Emergency industry guidance.

September 23, 2022

On September 21, 2022, the U.S. Food and Drug Administration (FDA) granted regular approval to selpercatinib (Retevmo®) for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a rearranged during transfection (RET) gene fusion and accelerated approval for adults with locally advanced or metastatic solid tumors with a RET gene fusion that progressed on or following prior systemic treatment or who have no satisfactory alternative treatment options.

September 22, 2022

Recognizing past actions, seeking forgiveness, and outlining its approach for the future, the American Nurses Association unanimously adopted a racial reckoning statement in June 2022. According to the association, the statement was the first step in acknowledging previous actions that have marginalized nurses of color and perpetuated systemic racism.

September 22, 2022

Health care is a hazardous professional industry. As a calling more than a career, providers understand the risks associated with patient interactions. Florence Nightingale’s environmental theory of nursing calls for nurses to tailor a patient’s surroundings to their treatment plan, and that includes creating a safe space for patients and providers alike.

September 21, 2022

Monitoring early-stage testicular cancer survivors for disease recurrence after surgery using either magnetic resonance imaging or fewer computed tomography scans is just as effective as more frequent intervals, researchers reported in study findings published in the Journal of Clinical Oncology.

September 20, 2022

By prohibiting discrimination on the basis of “race, color, national origin, sex, age, and disability,” the U.S. Department of Health and Human Services’ July 2022 proposed rule strengthens Section 1557 of the Affordable Care Act, improving civil rights protections for patients in certain federally funded health programs.